Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HPV testing in cervical screening.

× No keyword cloud information.

11 in total

1. Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection?

Authors: R Reid; M D Greenberg; A Lorincz; A B Jenson; C R Laverty; M Husain; Y Daoud; B Zado; T White; D Cantor
Journal: Am J Obstet Gynecol Date: 1991-06 Impact factor: 8.661

2. Accelerated decline in cervical cancer mortality in England and Wales.

Authors: P Sasieni; J Cuzick; E Farmery
Journal: Lancet Date: 1995-12-09 Impact factor: 79.321

3. A cervical smear review in women developing cervical carcinoma with particular reference to age, false negative cytology and the histologic type of the carcinoma.

Authors: C.M. Stanbridge; B.A. Suleman; R.V. Persad; S. El-Khatib
Journal: Int J Gynecol Cancer Date: 1992-03 Impact factor: 3.437

4. Prevention of colorectal cancer by once-only sigmoidoscopy.

Authors: W S Atkin; J Cuzick; J M Northover; D K Whynes
Journal: Lancet Date: 1993-03-20 Impact factor: 79.321

5. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

Authors: J T Cox; A T Lorincz; M H Schiffman; M E Sherman; A Cullen; R J Kurman
Journal: Am J Obstet Gynecol Date: 1995-03 Impact factor: 8.661

6. Invasive cancer of the cervix in women with mild dyskaryosis followed up cytologically.

Authors: W P Soutter; A Fletcher
Journal: BMJ Date: 1994-05-28

7. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors: F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal: J Natl Cancer Inst Date: 1995-06-07 Impact factor: 13.506

8. Human papillomavirus testing in primary cervical screening.

Authors: J Cuzick; A Szarewski; G Terry; L Ho; A Hanby; P Maddox; M Anderson; G Kocjan; S T Steele; J Guillebaud
Journal: Lancet Date: 1995-06-17 Impact factor: 79.321

9. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens.

Authors: K Elfgren; P Bistoletti; L Dillner; J M Walboomers; C J Meijer; J Dillner
Journal: Am J Obstet Gynecol Date: 1996-03 Impact factor: 8.661

10. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group.

Authors: P D Sasieni; J Cuzick; E Lynch-Farmery
Journal: Br J Cancer Date: 1996-04 Impact factor: 7.640